Respiratory

Respiratory diseases range from the common cold to life-threatening conditions such as bacterial pneumonia or pulmonary embolism. Because they are a widespread and prevalent cause of illness and death affecting millions of people worldwide, respiratory therapies are key to many drug development programs.

With decades of experience in respiratory drug discovery and development, Ricerca offers a complete list of validated respiratory-related in vivo models, using a broad panel of outcome measures.

Included on our respiratory team are directors with extensive industry experience who have authored numerous peer-reviewed published articles in the respiratory field. All have significant experience in preclinical pharmacology and drug development, and many have served as principal scientists and section leaders at major pharmaceutical companies.

Supporting services

• Histology

• Histopathology

• Biomarker – immunohistochemistry

• Screening and profiling assays

• ImmunoSignal™ – mediator release analysis

• OncoPanel™ – anti-cancer profiling and screening

• Early safety screening – cellular toxicity

• ADME/DMPK services